Cytomegaloviral control of MHC class I function in the mouse

被引:80
作者
Hengel, H
Reusch, U
Gutermann, A
Ziegler, H
Jonjic, S
Lucin, P
Koszinowski, UH
机构
[1] Univ Munich, Max Von Pettenkofer Inst, Lehrstuhl Virol, D-80336 Munich, Germany
[2] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka, Croatia
[3] Univ Rijeka, Fac Med, Dept Physiol & Immunol, Rijeka, Croatia
关键词
D O I
10.1111/j.1600-065X.1999.tb01291.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cytomegaloviruses (CMVs) represent prototypic viruses of the beta-subgroup of herpesviruses. Murine cytomegalovirus (MCMV) infects mice as its natural host. Among viruses, CMVs have evolved the most extensive genetic repertoire to subvert MHC class I functions. To date three MCMV proteins have been identified which affect MHC I complexes. They are encoded by members of large virus-specific gene Families located at either flanking region of the 235 kb MCMV genome. The MHC I subversive genes belong to the early class of genes and code for type I transmembrane glycoproteins. The ml52-encoded 37/40 kDa glycoprotein interacts with MHC I transiently and retains class I complexes in the endoplasmic reticulum (ER) Golgi intermediate compartment on its journey to the endolysosome. In contrast, the m06-encoded glycoprotein of 48 kDa complexes tightly with ternary MHC class I molecules in the ER. Due to sorting signals in its cytoplasmic tail, gp48 redirects MHC I to endolysosomal compartments for proteolytic destruction. Likewise, the 34 kDa glycoprotein encoded by m04 binds tightly to MHC class I complexes in the ER but the gp34/MHC I complex reaches the plasma membrane. The CD8(+) T-cell-dependent attenuation of a m152 deletion mutant virus proves for the first time that inhibition of antigen presentation is indeed essential for the biological fitness of CMVs in vivo.
引用
收藏
页码:167 / 176
页数:10
相关论文
共 65 条
[1]   The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP [J].
Ahn, K ;
Gruhler, A ;
Galocha, B ;
Jones, TR ;
Wiertz, EJHJ ;
Ploegh, HL ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
IMMUNITY, 1997, 6 (05) :613-621
[2]   Human cytomegalovirus inhibits antigen presentation by a sequential multistep process [J].
Ahn, KS ;
Angulo, A ;
Ghazal, P ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10990-10995
[3]   EVIDENCE THAT TRANSPORTERS ASSOCIATED WITH ANTIGEN-PROCESSING TRANSLOCATE A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I-BINDING PEPTIDE INTO THE ENDOPLASMIC-RETICULUM IN AN ATP-DEPENDENT MANNER [J].
ANDROLEWICZ, MJ ;
ANDERSON, KS ;
CRESSWELL, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (19) :9130-9134
[4]   MHC CLASS-II-ASSOCIATED INVARIANT CHAIN CONTAINS A SORTING SIGNAL FOR ENDOSOMAL COMPARTMENTS [J].
BAKKE, O ;
DOBBERSTEIN, B .
CELL, 1990, 63 (04) :707-716
[5]   INTERFERON-GAMMA STIMULATION MODULATES THE PROTEOLYTIC ACTIVITY AND CLEAVAGE SITE PREFERENCE OF 20S MOUSE PROTEASOMES [J].
BOES, B ;
HENGEL, H ;
RUPPERT, T ;
MULTHAUP, G ;
KOSZINOWSKI, UH ;
KLOETZEL, PM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (03) :901-909
[6]   AN ADENOVIRUS TYPE-2 GLYCOPROTEIN BLOCKS CELL-SURFACE EXPRESSION OF HUMAN HISTOCOMPATIBILITY CLASS-I ANTIGENS [J].
BURGERT, HG ;
KVIST, S .
CELL, 1985, 41 (03) :987-997
[7]   AN EARLY EVENT IN MURINE CYTOMEGALOVIRUS REPLICATION INHIBITS PRESENTATION OF CELLULAR ANTIGENS TO CYTOTOXIC LYMPHOCYTES-T [J].
CAMPBELL, AE ;
SLATER, JS ;
CAVANAUGH, VJ ;
STENBERG, RM .
JOURNAL OF VIROLOGY, 1992, 66 (05) :3011-3017
[8]  
CHEE MS, 1990, CURR TOP MICROBIOL, V154, P125
[9]   PRESENTATION OF CMV IMMEDIATE-EARLY ANTIGEN TO CYTOLYTIC LYMPHOCYTE-T IS SELECTIVELY PREVENTED BY VIRAL GENES EXPRESSED IN THE EARLY PHASE [J].
DELVAL, M ;
MUNCH, K ;
REDDEHASE, MJ ;
KOSZINOWSKI, UH .
CELL, 1989, 58 (02) :305-315
[10]   CYTOMEGALOVIRUS PREVENTS ANTIGEN PRESENTATION BY BLOCKING THE TRANSPORT OF PEPTIDE-LOADED MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULES INTO THE MEDIAL-GOLGI COMPARTMENT [J].
DELVAL, M ;
HENGEL, H ;
HACKER, H ;
HARTLAUB, U ;
RUPPERT, T ;
LUCIN, P ;
KOSZINOWSKI, UH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (03) :729-738